See all FAQs Important safety information and common side effects Do not use with other GLP-1 receptor agonist medications, or any other products containing GLP-1s
Project IDs 322900939 (M03, M05) (to NM), GRK2816 and BI1292/12-1 (to ALB), 520275106 (to the Emmy Noether Research Group), and SFB TRR 219 - 322900939 - M-07 (to FK)
In contrast, Noom states that their dosing starts at 25% or less of the standard 0.25 mg dose and escalates at a personalized rate. While microdosing GLP-1 medications may provide a more personalized experience, there are still questions regarding the safety of this practice as there are currently no published studies on the process, and the microdoses may come from a compounding pharmacy
You will meet with real providers and nutritionists, to start your weight loss journey
I can walk you through our other GLP-1 offerings
Prescriptions are filled and shipped directly to your door in discreet packaging, where available